Compare VICR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICR | CRL |
|---|---|---|
| Founded | 1981 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 13.1B |
| IPO Year | 1995 | 1999 |
| Metric | VICR | CRL |
|---|---|---|
| Price | $192.16 | $298.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 18 |
| Target Price | ★ $393.75 | $315.53 |
| AVG Volume (30 Days) | ★ 954.5K | 931.3K |
| Earning Date | 10-20-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1764.29 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | $452,701,000.00 | ★ $1,857,601,000.00 |
| Revenue This Year | $57.77 | N/A |
| Revenue Next Year | $52.22 | $2.55 |
| P/E Ratio | $499.61 | ★ N/A |
| Revenue Growth | ★ 26.08 | 10.48 |
| 52 Week Low | $57.55 | $146.20 |
| 52 Week High | $382.65 | $333.30 |
| Indicator | VICR | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 32.94 | 54.34 |
| Support Level | $169.82 | $267.27 |
| Resistance Level | $205.69 | $303.31 |
| Average True Range (ATR) | 18.57 | 12.07 |
| MACD | -11.45 | -0.24 |
| Stochastic Oscillator | 2.37 | 29.08 |
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others. The principal markets for the Company's power converters and systems are large original equipment manufacturers (OEMs), original design manufacturers (ODMs) and their contract manufacturers, and smaller, lower volume users, which are broadly distributed across several market areas.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.